|
MediciNova (Nasdaq: MNOV) Targets Multi-Billion Dollar Acute Asthma and CNS …
BiotechStockTrader.com (blog) In particular, the company is targeting the multi-billion dollar acute asthma and central nervous system markets. With more than two million patients per … |
View full post on asthma – Google News